allodynia glp 1 treatment is being reported with GLP-1 medications, It is a heightened sensitivity to touch that can feel like pain. We are seeing it more at higher doses, The important point is that it appears Frontiers | GLP-1 Receptor Agonists:

Commitment Structure A year-long program commitment works well for patients who want accountability built into their treatment structure and who are ready to engage with a curriculum-based approach

The two-hour window is a conservative, low-risk approach adopted from the broader drug-interaction guidance in the dulaglutide prescribing information

When evaluating retatrutide research data, the safety profile appears manageable and consistent with the GLP-1/GIP/glucagon receptor agonist class

Hong Kong university rejects GLP-1 link to blindness in 80,000 patients Meta-analysis examines optic nerve risk across diabetes and cardiac patients The Department of Medicine under the School of Clinical Medicine at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) said a large-scale review of global clinical trial data found no significant association between GLP-1 receptor agonist use and ischaemic optic neuropathy, according to a press release

It's also worth noting that many initial studies focused on individuals without pre-existing major depression